BIOMAT Database Logo BIOMAT Database Logo

Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics. 1981

E A Ward, and G M Ward, and R C Turner

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin

Related Publications

E A Ward, and G M Ward, and R C Turner
Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.
November 1979, Diabetologia,
E A Ward, and G M Ward, and R C Turner
Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics.
April 1987, Archives of internal medicine,
E A Ward, and G M Ward, and R C Turner
Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.
February 1981, Diabetologia,
E A Ward, and G M Ward, and R C Turner
Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
July 1990, The Journal of the Association of Physicians of India,
E A Ward, and G M Ward, and R C Turner
Sulphonylurea effects on insulin secretion in islets desensitized to glucose.
September 1990, Pancreas,
E A Ward, and G M Ward, and R C Turner
Effect of bepridil on metabolic control and insulin secretion in diabetics.
January 1988, European journal of clinical pharmacology,
E A Ward, and G M Ward, and R C Turner
HYPOTHYROIDISM IN DIABETICS TREATED WITH SULPHONYLUREA.
September 1965, Lancet (London, England),
E A Ward, and G M Ward, and R C Turner
Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion.
January 1987, European journal of clinical pharmacology,
E A Ward, and G M Ward, and R C Turner
The effect of sulphonylurea therapy on in vivo insulin sensitivity in non-insulin dependent diabetics.
April 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
E A Ward, and G M Ward, and R C Turner
Effect of nicardipine on insulin secretion, glucose and lipid metabolism in hypertensive, non-insulin dependent diabetics.
January 1989, European journal of clinical pharmacology,
Copied contents to your clipboard!